Graft Position and Pulmonary Function After Single Lung Transplantation for Obstructive Lung Disease

CHEST Journal ◽  
1993 ◽  
Vol 103 (2) ◽  
pp. 444-448 ◽  
Author(s):  
Stephanie M. Levine ◽  
Antonio Anzueto ◽  
William J. Gibbons ◽  
John H. Calhoon ◽  
Stephen G. Jenkinson ◽  
...  
CHEST Journal ◽  
1991 ◽  
Vol 100 (1) ◽  
pp. 106-111 ◽  
Author(s):  
William J. Gibbons ◽  
Stephanie M. Levine ◽  
Charles L. Bryan ◽  
Jay Segarra ◽  
John H. Calhoon ◽  
...  

1991 ◽  
Vol 101 (4) ◽  
pp. 623-632 ◽  
Author(s):  
G.A. Patterson ◽  
J.R. Maurer ◽  
T.J. Williams ◽  
P.G. Cardoso ◽  
M. Scavuzzo ◽  
...  

1981 ◽  
Vol 1 (5) ◽  
pp. 461-466 ◽  
Author(s):  
Mary Therse Hynak ◽  
Mohamed S. Al-Ibrahim ◽  
Robert M. Russell ◽  
Gina Stanko ◽  
C.V.J. Verghease ◽  
...  

2012 ◽  
Vol 19 (1) ◽  
pp. e3-e4 ◽  
Author(s):  
Dawei Yang ◽  
Jennifer M Wilson ◽  
Chunxue Bai ◽  
John Yee ◽  
Pearce G Wilcox ◽  
...  

Acute exacerbations of interstitial lung disease present as clinical deteriorations, with progressive hypoxemia and parenchymal consolidation not related to infection, heart failure or thromboembolic disease. Following single lung transplantation, patients receive maintenance immunosuppression, which could mitigate the development of acute exacerbations in the native lung. A 66-year-old man with fibrotic, nonspecific interstitial pneumonitis presented with fever, hypoxemia and parenchymal consolidation limited to the native lung four years after single lung transplantation. Investigations were negative for infection, heart failure and thromboembolic disease. The patient worsened over the course of one week despite broad-spectrum antimicrobial therapy, but subsequently improved promptly with augmentation of prednisone dosed to 50 mg daily and addition of N-acetylcysteine. Hence, the patient fulfilled the criteria for a diagnosis of an acute exacerbation of pulmonary fibrosis in his native lung. Clinicians should consider acute exacerbation of parenchymal lung disease of the native lung in the differential diagnosis of progressive respiratory deterioration following single lung transplantation for pulmonary fibrosis.


2009 ◽  
Vol 16 (3) ◽  
pp. 75-80 ◽  
Author(s):  
Christopher R Gilbert ◽  
Seth M Arum ◽  
Cecilia M Smith

Vitamin D deficiency is increasingly being recognized as a prevalent problem in the general population. Patients with chronic lung diseases such as asthma, cystic fibrosis, chronic obstructive lung disease and interstitial pneumonia appear to be at increased risk for vitamin D deficiency for reasons that are not clear.Several studies indicate that vitamin D possesses a range of anti-inflammatory properties and may be involved in processes other than the previously believed functions of calcium and phosphate homeostasis. Various cytokines, cellular elements, oxidative stress and protease/antiprotease levels appear to affect lung fibroproliferation, remodelling and function, which may be influenced by vitamin D levels. Chronic lung diseases such as asthma and chronic obstructive lung disease have also been linked to vitamin D on a genetic basis. This immune and genetic influence of vitamin D may influence the pathogenesis of chronic lung diseases. A recent observational study notes a significant association between vitamin D deficiency and decreased pulmonary function tests in a large ambulatory population.The present review will examine the current literature regarding vitamin D deficiency, its prevalence in patients with chronic lung disease, vitamin D anti-inflammatory properties and the role of vitamin D in pulmonary function.


CHEST Journal ◽  
1989 ◽  
Vol 96 (6) ◽  
pp. 1247-1251 ◽  
Author(s):  
Norman Wolkove ◽  
Esther Dajczman ◽  
Antoinette Colacone ◽  
Harvey Kreisman

Sign in / Sign up

Export Citation Format

Share Document